The effect and mechanism of low-dose esketamine in neuropathic pain-related depression-like behavior in rats.
Brain Research November 15, 2024 Lijuan Wang, Shuwu Zhao, Jiali Shao et al. 7 citations
Clinical evidence suggests that Esketamine (ESK) is an effective treatment for depression. However, the effects of Esketamine in treating depression-like behavior induced by neuropathic pain is unclear. The underlying molecular mechanisms require further investigation to provide new therapeutic targets for the treatment of clinical neuropathic pain-related depression. A neuropathic pain-related...